KURVE THERAPEUTICS
Kurve Therapeutics engages in the development of treatments for neurodegenerative diseases. Its drug delivery technology is designed to target the most difficult part of the treatment process โ getting medication through the blood-brain barrier and into the brain. Through the development of their patented Controlled Particle Dispersion technology, Kurve Therapeutics aims to reshape the landscape of cognitive aging, neurodegenerative diseases, and related disorders. Its next-generation technol... ogy has been shown to deliver up to 30x more disease-modifying medication directly to the brain than infusions in several Phase II studies. This allows for significant dose flexibility away from toxic doses for a safer, more efficacious therapy. While traditional treatment options continually prove ineffective at stopping neurodegenerative disease progression and often lead to toxicity or continued decline, Kurve is developing a new disease-modifying approach.
KURVE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Medical Therapeutics
Address:
Lynnwood, Washington, United States
Country:
United States
Website Url:
http://www.kurvetx.com
Total Employee:
1+
Status:
Active
Contact:
(425) 640-9249
Email Addresses:
[email protected]
Total Funding:
53.49 M USD
Technology used in webpage:
SPF Amazon GoDaddy DNS AWS Global Accelerator
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.kurvetx.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Kurve Therapeutics"
Home - Kurve Therapeutics
The Future of Systemic and Central Nervous System (CNS) Therapies Bringing solutions to clinical unmet needs Chronic sinusitis affects 30 million patients in the U.S. alone. Central โฆSee details»
Kurve Therapeutics - Crunchbase Company Profile & Funding
Organization. Kurve Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email [email protected]; โฆSee details»
Our Team - Kurve Therapeutics
Our Team The Team Behind Kurve Meet Our Medtech Innovators Marc Giroux CHAIRMAN & CHIEF EXECUTIVE OFFICER Mr. Giroux is a 20-year medical industry veteran with involvement in more than 35 human-use clinical trials in โฆSee details»
Kurve Therapeutics Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Kurve Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Kurve Therapeutics, Inc. | LinkedIn
Kurve Therapeutics, Inc. Biotechnology Lynnwood, Washington 229 followers Next-generation drug delivery technology designed to bypass the blood-brain barrier for CNS disorder treatmentsSee details»
Kurve Therapeutics, Innovative Medtech and Specialty-Drug โฆ
Aug 9, 2022 Kurve Therapeutics, a next-generation medtech innovator focused on developing treatments for neurodegenerative diseases, announced it has filed a Form 1-A preliminary โฆSee details»
Orgenesis and Kurve Therapeutics Announce Pre-Clinical
Dec 20, 2022 The study was conducted by an independent pre-clinical research organization. In the study, the cell-based product was successfully delivered into the brain of mice via โฆSee details»
Kurve Therapeutics, Inc. Announces Development of New โฆ
Led by a team of experienced entrepreneurs with successful track records in biotech, pharmaceuticals, neuroscience, and device technology, Kurve Therapeutics is paving the way โฆSee details»
Compassionate Use - Kurve Therapeutics
โI have used the Kurve technology platform to treat over 150 patients with any of 10 degenerative brain diseases, including Alzheimerโs, Parkinsonโs, Lewy Body, multi-system atrophy, ALS, โฆSee details»
Kurve Therapeutics, Inc. Announces Development of โฆ
Mar 15, 2023 Visit kurvetx.com to learn more about how Kurve is reshaping the future of neurodegenerative disease treatments. Media Contact: Marc Giroux (425) 640-9249 [email protected]See details»
Kurve Therapeutics, Innovative Medtech and Specialty โฆ
Aug 9, 2022 Kurve Therapeutics ' drug delivery technology is designed to target the most difficult part of the treatment process โ getting medication through the blood-brain barrier and into the brain.See details»
Kurve Therapeutics Announces Next-Gen Technology Designed โฆ
Jun 14, 2022 Kurve Therapeutics has succeeded in bypassing the blood-brain barrier with their patented Controlled Particle Dispersion® (CPD) technology, creating new hope in the โฆSee details»
Frequently Asked Questions - info.kurvetx.com
Are Kurve products safe? Kurveโs intranasal insulin (Intrulin โข) has an excellent safety record to date, documented in several published clinical studies involving over 300 patients (175 with โฆSee details»
Kurve Technology - Overview, News & Similar companies
Dec 19, 2022 Kurve Technology contact info: Phone number: (425) 640-9249 Website: www.kurvetx.com What does Kurve Technology do? Kurve Technology offers pharmaceutical โฆSee details»
Kurve Therapeutics, Inc. Announces Development of New
Mar 15, 2023 Visit kurvetx.com to learn more about how Kurve is reshaping the future of neurodegenerative disease treatments. Media Contact: Marc Giroux (425) 640-9249 โฆSee details»
Media - Kurve Therapeutics
Sep 23, 2023 Resources Press Releases Peer Reviews Infographic Press Releases Peer Reviews Infographic Press Releases Kurve Therapeutics, Inc. Announces Development of โฆSee details»
Orgenesis and Kurve Therapeutics Announce Pre-Clinical Study โฆ
Dec 20, 2022 The study was conducted by an independent pre-clinical research organization. In the study, the cell-based product was successfully delivered into the brain of mice via โฆSee details»
The Solution - Kurve Therapeutics
The solution The ViaNaseโข Difference Researchers and scientists have spent the last 25 years trying and failing to develop effective treatments for many unmet needs including brain โฆSee details»
Curve Therapeutics - Curve Therapeutics
Oct 2, 2024 Pipeline Challenging cancer targets. We are currently deploying our platform to build a pipeline of first-in-class small molecule drugs to initially address high priority cancer targets โฆSee details»
Orgenesis and Kurve Therapeutics Announce Pre-Clinical Study โฆ
Dec 20, 2022 The study was conducted by an independent pre-clinical research organization. In the study, the cell-based product was successfully delivered into the brain of mice via โฆSee details»